Defective propagation of signals generated by sympathetic nerve stimulation in the liver of connexin32-deficient mice

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Eric Nelles - , University of Bonn (Author)
  • Christoph Bützler - , University of Bonn (Author)
  • Dirk Jung - , University of Bonn (Author)
  • Achim Temme - , University of Bonn (Author)
  • Heinz Dieter Gabriel - , University of Bonn (Author)
  • Ursula Dahl - , University of Bonn (Author)
  • Otto Traub - , University of Bonn (Author)
  • Frank Stümpel - , University of Göttingen (Author)
  • Kurt Jungermann - , University of Göttingen (Author)
  • Jürgen Zielasek - , University of Würzburg (Author)
  • Klaus V. Toyka - , University of Würzburg (Author)
  • Rolf Dermietzel - , University of Regensburg (Author)
  • Klaus Willecke - , University of Bonn (Author)

Abstract

The gap junctional protein connexin32 is expressed in hepatocytes, exocrine pancreatic cells, Schwann cells, and other cell types. We have inactivated the connexin32 gene by homologous recombination in the mouse genome and have generated homozygous connexin32-deficient mice that were viable and fertile but weighed on the average ≃17% less than wild-type controls. Electrical stimulation of sympathetic nerves in connexin32.deficient liver triggered a 78% lower amount of glucose mobilization from glycogen stores, when compared with wild-type liver. Thus, connexin32-containing gap junctions are essential in mouse liver for maximal intercellular propagation of the noradrenaline signal from the periportal (upstream) area, where it is received from sympathetic nerve endings, to perivenous (downstream) hepatocytes. In connexin32-defective liver, the amount of connexin26 protein expressed was found to be lower than in wild- type liver, and the total area of gap junction plaques was ≃1000-fold smaller than in wild-type liver. In contrast to patients with connexin32 defects suffering from X chromosome-linked Charcot-Marie-Tooth disease (CMTX) due to demyelination in Schwann cells of peripheral nerves, connexin32- deficient mice did not show neurological abnormalities when analyzed at 3 months of age. It is possible, however, that they may develop neurodegenerative symptoms at older age.

Details

Original languageEnglish
Pages (from-to)9565-9570
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume93
Issue number18
Publication statusPublished - 3 Sept 1996
Peer-reviewedYes
Externally publishedYes

External IDs

Scopus 0343687249
PubMed 8790370

Keywords

ASJC Scopus subject areas

Keywords

  • Charcot-Marie-Tooth disease (CMTX), gap junctions, glucose release, metabolic cooperation